-
1
-
-
0029741182
-
The natural history of chronic pain in the community: a better prognosis than in the clinic?
-
MacFarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ. The natural history of chronic pain in the community: a better prognosis than in the clinic?. J Rheumatol 1996, 23:1617-1620.
-
(1996)
J Rheumatol
, vol.23
, pp. 1617-1620
-
-
MacFarlane, G.J.1
Thomas, E.2
Papageorgiou, A.C.3
Schollum, J.4
Croft, P.R.5
Silman, A.J.6
-
2
-
-
67651225436
-
Clinical manifestations and diagnosis of fibromyalgia
-
10.1016/j.rdc.2009.05.009, 19647138
-
Bennett RM. Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am 2009, 35:215-232. 10.1016/j.rdc.2009.05.009, 19647138.
-
(2009)
Rheum Dis Clin North Am
, vol.35
, pp. 215-232
-
-
Bennett, R.M.1
-
3
-
-
79955665995
-
Improving the recognition and diagnosis of fibromyalgia
-
10.4065/mcp.2010.0738, 3084648, 21531887, Fibro Collaborative
-
Arnold LM, Clauw DJ, McCarberg BH, Fibro Collaborative Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011, 86:457-464. 10.4065/mcp.2010.0738, 3084648, 21531887, Fibro Collaborative.
-
(2011)
Mayo Clin Proc
, vol.86
, pp. 457-464
-
-
Arnold, L.M.1
Clauw, D.J.2
McCarberg, B.H.3
-
4
-
-
0025266660
-
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee
-
10.1002/art.1780330203, 2306288
-
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172. 10.1002/art.1780330203, 2306288.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 160-172
-
-
Wolfe, F.1
Smythe, H.A.2
Yunus, M.B.3
Bennett, R.M.4
Bombardier, C.5
Goldenberg, D.L.6
Tugwell, P.7
Campbell, S.M.8
Abeles, M.9
Clark, P.10
Fam, A.G.11
Farber, S.J.12
Fiechtner, J.J.13
Franklin, C.M.14
Gatter, R.A.15
Hamaty, D.16
Lessard, J.17
Lichtbroun, A.S.18
Masi, A.T.19
McCain, G.A.20
Reynolds, W.J.21
Romano, T.J.22
Russell, I.J.23
Sheon, R.P.24
more..
-
5
-
-
0028890678
-
The prevalence and characteristics of fibromyalgia in the general population
-
10.1002/art.1780380104, 7818567
-
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28. 10.1002/art.1780380104, 7818567.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 19-28
-
-
Wolfe, F.1
Ross, K.2
Anderson, J.3
Russell, I.J.4
Hebert, L.5
-
6
-
-
0035432753
-
Classification, epidemiology, and natural history of fibromyalgia
-
10.1007/s11916-001-0021-2, 11403735
-
White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep 2001, 5:320-329. 10.1007/s11916-001-0021-2, 11403735.
-
(2001)
Curr Pain Headache Rep
, vol.5
, pp. 320-329
-
-
White, K.P.1
Harth, M.2
-
7
-
-
84876732835
-
Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project
-
10.1002/acr.21896, 23203795
-
Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken) 2013, 65:786-792. 10.1002/acr.21896, 23203795.
-
(2013)
Arthritis Care Res (Hoboken)
, vol.65
, pp. 786-792
-
-
Vincent, A.1
Lahr, B.D.2
Wolfe, F.3
Clauw, D.J.4
Whipple, M.O.5
Oh, T.H.6
Barton, D.L.7
St Sauver, J.8
-
8
-
-
79957809749
-
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia
-
10.3899/jrheum.100594, 21285161
-
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011, 38:1113-1122. 10.3899/jrheum.100594, 21285161.
-
(2011)
J Rheumatol
, vol.38
, pp. 1113-1122
-
-
Wolfe, F.1
Clauw, D.J.2
Fitzcharles, M.A.3
Goldenberg, D.L.4
Häuser, W.5
Katz, R.S.6
Mease, P.7
Russell, A.S.8
Russell, I.J.9
Winfield, J.B.10
-
9
-
-
8544239393
-
Management of fibromyalgia syndrome
-
10.1001/jama.292.19.2388, 15547167
-
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004, 292:2388-2395. 10.1001/jama.292.19.2388, 15547167.
-
(2004)
JAMA
, vol.292
, pp. 2388-2395
-
-
Goldenberg, D.L.1
Burckhardt, C.2
Crofford, L.3
-
10
-
-
41849093775
-
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
-
EULAR
-
Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Samsøe B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Späth M, Choy EH, EULAR EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008, 67:536-541. EULAR.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 536-541
-
-
Carville, S.F.1
Arendt-Nielsen, S.2
Bliddal, H.3
Blotman, F.4
Branco, J.C.5
Buskila, D.6
Da Silva, J.A.7
Danneskiold-Samsøe, B.8
Dincer, F.9
Henriksson, C.10
Henriksson, K.G.11
Kosek, E.12
Longley, K.13
McCarthy, G.M.14
Perrot, S.15
Puszczewicz, M.16
Sarzi-Puttini, P.17
Silman, A.18
Späth, M.19
Choy, E.H.20
more..
-
11
-
-
0031693130
-
Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo
-
Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998, 18:13-19.
-
(1998)
Int J Clin Pharmacol Res
, vol.18
, pp. 13-19
-
-
Biasi, G.1
Manca, S.2
Manganelli, S.3
Marcolongo, R.4
-
12
-
-
0033779511
-
Efficacy of tramadol in treatment of pain in fibromyalgia
-
10.1097/00124743-200010000-00003, 19078481
-
Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000, 6:250-257. 10.1097/00124743-200010000-00003, 19078481.
-
(2000)
J Clin Rheumatol
, vol.6
, pp. 250-257
-
-
Russell, I.J.1
Kamin, M.2
Bennett, R.M.3
Schnitzer, T.J.4
Green, J.A.5
Katz, W.A.6
-
13
-
-
0037716856
-
Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study
-
10.1016/S0002-9343(03)00116-5, 12753877
-
Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003, 114:537-545. 10.1016/S0002-9343(03)00116-5, 12753877.
-
(2003)
Am J Med
, vol.114
, pp. 537-545
-
-
Bennett, R.M.1
Kamin, M.2
Karim, R.3
Rosenthal, N.4
-
14
-
-
80052402343
-
Fibromyalgia: from pathophysiology to therapy
-
10.1038/nrrheum.2011.98, 21769128
-
Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011, 7:518-527. 10.1038/nrrheum.2011.98, 21769128.
-
(2011)
Nat Rev Rheumatol
, vol.7
, pp. 518-527
-
-
Schmidt-Wilcke, T.1
Clauw, D.J.2
-
15
-
-
79955601506
-
Lyrica (pregabalin) prescribing information
-
New York: Pfizer Inc
-
Lyrica (pregabalin) prescribing information. 2012, New York: Pfizer Inc.
-
(2012)
-
-
-
16
-
-
84873261449
-
Cymbalta (duloxetine HCl) prescribing information
-
Indianapolis, IN: Eli Lilly and Co
-
Cymbalta (duloxetine HCl) prescribing information. 2012, Indianapolis, IN: Eli Lilly and Co.
-
(2012)
-
-
-
17
-
-
84876934537
-
Savella (milnacipran HCl) prescribing information
-
St Louis, MO: Forest Pharmaceuticals, Inc
-
Savella (milnacipran HCl) prescribing information. 2012, St Louis, MO: Forest Pharmaceuticals, Inc.
-
(2012)
-
-
-
18
-
-
84860767037
-
Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia
-
10.1016/j.clinthera.2012.03.003, 22503162
-
Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G, Petersel D. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia. Clin Ther 2012, 34:1092-1102. 10.1016/j.clinthera.2012.03.003, 22503162.
-
(2012)
Clin Ther
, vol.34
, pp. 1092-1102
-
-
Arnold, L.M.1
Emir, B.2
Murphy, T.K.3
Zeiher, B.G.4
Pauer, L.5
Scott, G.6
Petersel, D.7
-
19
-
-
77953123321
-
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia
-
10.1016/j.semarthrit.2008.11.001, 19152958
-
Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum 2010, 39:454-464. 10.1016/j.semarthrit.2008.11.001, 19152958.
-
(2010)
Semin Arthritis Rheum
, vol.39
, pp. 454-464
-
-
Mease, P.J.1
Russell, I.J.2
Kajdasz, D.K.3
Wiltse, C.G.4
Detke, M.J.5
Wohlreich, M.M.6
Walker, D.J.7
Chappell, A.S.8
-
20
-
-
75249097956
-
Durability of therapeutic response to milnacipran for fibromyalgia: results of a randomized, double-blind, monotherapy 6-month extension study
-
10.1111/j.1526-4637.2009.00755.x, 20002596
-
Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM. Durability of therapeutic response to milnacipran for fibromyalgia: results of a randomized, double-blind, monotherapy 6-month extension study. Pain Med 2010, 11:180-194. 10.1111/j.1526-4637.2009.00755.x, 20002596.
-
(2010)
Pain Med
, vol.11
, pp. 180-194
-
-
Goldenberg, D.L.1
Clauw, D.J.2
Palmer, R.H.3
Mease, P.4
Chen, W.5
Gendreau, R.M.6
-
21
-
-
79952286187
-
Improvements in fibromyalgia symptoms are sustained for 1 year with milnacipran treatment: results from 2 double-blind, dose-controlled extension studies [abstract]
-
Ferrera R, Palmer R, Chen W, Gendreau R. Improvements in fibromyalgia symptoms are sustained for 1 year with milnacipran treatment: results from 2 double-blind, dose-controlled extension studies [abstract]. J Pain 2009, 10(4 Suppl):S60.
-
(2009)
J Pain
, vol.10
, Issue.4 SUPPL
-
-
Ferrera, R.1
Palmer, R.2
Chen, W.3
Gendreau, R.4
-
22
-
-
84887817675
-
A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia
-
Arnold LM, Palmer RH, Ma Y. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. Clin J Pain
-
Clin J Pain
-
-
Arnold, L.M.1
Palmer, R.H.2
Ma, Y.3
-
23
-
-
26444518188
-
Efficacy of milnacipran in patients with fibromyalgia
-
Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease PJ, McLean SA, Clauw DJ. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005, 32:1975-1985.
-
(2005)
J Rheumatol
, vol.32
, pp. 1975-1985
-
-
Gendreau, R.M.1
Thorn, M.D.2
Gendreau, J.F.3
Kranzler, J.D.4
Ribeiro, S.5
Gracely, R.H.6
Williams, D.A.7
Mease, P.J.8
McLean, S.A.9
Clauw, D.J.10
-
24
-
-
64849117499
-
The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial
-
A published erratum appears in J Rheumatol 2009, 36:661., 10.3899/jrheum.080734, 19132781
-
Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009, 36:398-409. A published erratum appears in J Rheumatol 2009, 36:661., 10.3899/jrheum.080734, 19132781.
-
(2009)
J Rheumatol
, vol.36
, pp. 398-409
-
-
Mease, P.J.1
Clauw, D.J.2
Gendreau, R.M.3
Rao, S.G.4
Kranzler, J.5
Chen, W.6
Palmer, R.H.7
-
25
-
-
57649234533
-
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
-
Published errata appear in Clin Ther 2009, 31:446, and Clin Ther 2009 31:1617., 10.1016/j.clinthera.2008.11.009, 19108787
-
Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008, 30:1988-2004. Published errata appear in Clin Ther 2009, 31:446, and Clin Ther 2009 31:1617., 10.1016/j.clinthera.2008.11.009, 19108787.
-
(2008)
Clin Ther
, vol.30
, pp. 1988-2004
-
-
Clauw, D.J.1
Mease, P.2
Palmer, R.H.3
Gendreau, R.M.4
Wang, Y.5
-
26
-
-
77956251773
-
Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial
-
10.1002/art.27559, 20496365
-
Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010, 62:2745-2756. 10.1002/art.27559, 20496365.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2745-2756
-
-
Arnold, L.M.1
Gendreau, R.M.2
Palmer, R.H.3
Gendreau, J.F.4
Wang, Y.5
-
27
-
-
84887824411
-
A study of milnacipran in patients with fibromyalgia: effects on 24-hour ambulatory blood pressure monitoring
-
A study of milnacipran in patients with fibromyalgia: effects on 24-hour ambulatory blood pressure monitoring. http://clinicaltrials.gov/ct2/show/NCT00618956
-
-
-
-
28
-
-
0034748159
-
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
-
10.1016/S0304-3959(01)00349-9, 11690728
-
Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158. 10.1016/S0304-3959(01)00349-9, 11690728.
-
(2001)
Pain
, vol.94
, pp. 149-158
-
-
Farrar, J.T.1
Young, J.P.2
LaMoreaux, L.3
Werth, J.L.4
Poole, R.M.5
-
29
-
-
0028948260
-
Comparison of self-reported fatigue in rheumatoid arthritis and controls
-
Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 1995, 22:639-643.
-
(1995)
J Rheumatol
, vol.22
, pp. 639-643
-
-
Belza, B.L.1
-
30
-
-
0026877917
-
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
-
10.1097/00005650-199206000-00002, 1593914
-
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
-
(1992)
Med Care
, vol.30
, pp. 473-483
-
-
Ware, J.E.1
Sherbourne, C.D.2
-
31
-
-
0028395482
-
Pain assessment: global use of the Brief Pain Inventory
-
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994, 23:129-138.
-
(1994)
Ann Acad Med Singapore
, vol.23
, pp. 129-138
-
-
Cleeland, C.S.1
Ryan, K.M.2
-
32
-
-
78651438037
-
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
-
A published erratum appears in Arthritis Res Ther 2009, 11:415., 10.1186/ar2783, 2745803, 19664287
-
Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009, 11:R120. A published erratum appears in Arthritis Res Ther 2009, 11:415., 10.1186/ar2783, 2745803, 19664287.
-
(2009)
Arthritis Res Ther
, vol.11
-
-
Bennett, R.M.1
Friend, R.2
Jones, K.D.3
Ward, R.4
Han, B.K.5
Ross, R.L.6
-
33
-
-
0028047160
-
Development and validation of a Multiple Ability Self-Report Questionnaire
-
10.1080/01688639408402620, 8150893
-
Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A. Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 1994, 16:93-104. 10.1080/01688639408402620, 8150893.
-
(1994)
J Clin Exp Neuropsychol
, vol.16
, pp. 93-104
-
-
Seidenberg, M.1
Haltiner, A.2
Taylor, M.A.3
Hermann, B.B.4
Wyler, A.5
-
34
-
-
73449097194
-
Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology
-
10.1097/AJP.0b013e3181b12dec, 19851161
-
Katz N. Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology. Clin J Pain 2009, 25:797-807. 10.1097/AJP.0b013e3181b12dec, 19851161.
-
(2009)
Clin J Pain
, vol.25
, pp. 797-807
-
-
Katz, N.1
-
35
-
-
43549104210
-
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin
-
10.1016/j.pain.2008.02.027, 18400400
-
Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008, 136:419-431. 10.1016/j.pain.2008.02.027, 18400400.
-
(2008)
Pain
, vol.136
, pp. 419-431
-
-
Crofford, L.J.1
Mease, P.J.2
Simpson, S.L.3
Young, J.P.4
Martin, S.A.5
Haig, G.M.6
Sharma, U.7
-
36
-
-
80052529130
-
The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia
-
10.1186/ar3306, 3132050, 21542893
-
Lee YC, Nassikas NJ, Clauw DJ. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther 2011, 13:211. 10.1186/ar3306, 3132050, 21542893.
-
(2011)
Arthritis Res Ther
, vol.13
, pp. 211
-
-
Lee, Y.C.1
Nassikas, N.J.2
Clauw, D.J.3
-
37
-
-
0026505492
-
"Reverse placebo effects": anticipation/anxiety at the possibility of receiving placebos
-
Okada F. "Reverse placebo effects": anticipation/anxiety at the possibility of receiving placebos. Ann Pharmacother 1992, 26:128.
-
(1992)
Ann Pharmacother
, vol.26
, pp. 128
-
-
Okada, F.1
-
38
-
-
84861181740
-
Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia
-
10.1185/03007995.2012.677418, 22429066
-
Saxe PA, Arnold LM, Palmer RH, Gendreau RM, Chen W. Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia. Curr Med Res Opin 2012, 28:815-821. 10.1185/03007995.2012.677418, 22429066.
-
(2012)
Curr Med Res Opin
, vol.28
, pp. 815-821
-
-
Saxe, P.A.1
Arnold, L.M.2
Palmer, R.H.3
Gendreau, R.M.4
Chen, W.5
-
39
-
-
40649095921
-
A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
-
Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, Sharma U. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008, 35:502-514.
-
(2008)
J Rheumatol
, vol.35
, pp. 502-514
-
-
Mease, P.J.1
Russell, I.J.2
Arnold, L.M.3
Florian, H.4
Young, J.P.5
Martin, S.A.6
Sharma, U.7
-
40
-
-
85035044195
-
Pristiq (desvenlafaxine) prescribing information
-
Philadelphia: Wyeth Pharmaceuticals Inc
-
Pristiq (desvenlafaxine) prescribing information. 2011, Philadelphia: Wyeth Pharmaceuticals Inc.
-
(2011)
-
-
-
41
-
-
84887820319
-
Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a double-blind, placebo-controlled, discontinuation study [abstract]
-
Clauw DJ, Mease P, Palmer RH, Trugman JM, Ma Y. Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a double-blind, placebo-controlled, discontinuation study [abstract]. Arthritis Rheum 2012, 64(10 Suppl):S417.
-
(2012)
Arthritis Rheum
, vol.64
, Issue.10 SUPPL
-
-
Clauw, D.J.1
Mease, P.2
Palmer, R.H.3
Trugman, J.M.4
Ma, Y.5
|